AMRX Amneal Pharmaceuticals Inc Class A

USD 4.29 -0.23 -5.088496
Icon

Amneal Pharmaceuticals Inc Class A Stock Analysis and Price Target COMMON STOCK | Drug Manufacturers - Specialty & Generic | NYE

stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.29

-0.23 (-5.09)%

USD 1.39B

1.40M

USD 5.75(+34.03%)

USD 6.00 (+39.86%)

Icon

AMRX

Amneal Pharmaceuticals Inc Class A (USD)
COMMON STOCK | NYE
USD 4.29
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.39B

USD 6.00 (+39.86%)

USD 4.29

Amneal Pharmaceuticals Inc Class A Stock Forecast

USD 5.75
(+34.03%)

Based on the Amneal Pharmaceuticals Inc Class A stock forecast from 3 analysts, the average analyst target price for Amneal Pharmaceuticals Inc Class A is USD 5.75 over the next 12 months. Amneal Pharmaceuticals Inc Class A’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Amneal Pharmaceuticals Inc Class A is Slightly Bearish, which is based on 5 positive signals and 8 negative signals. At the last closing, Amneal Pharmaceuticals Inc Class A’s stock price was USD 4.29. Amneal Pharmaceuticals Inc Class A’s stock price has changed by -4.45% over the past week, +13.79% over the past month and +79.50% over the last year.

No recent analyst target price found for Amneal Pharmaceuticals Inc Class A
No recent average analyst rating found for Amneal Pharmaceuticals Inc Class A

Company Overview Amneal Pharmaceuticals Inc Class A

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE...Read More

https://www.amneal.com

400 Crossing Boulevard, Bridgewater, NJ, United States, 08807

7,600

December

USD

USA

Adjusted Closing Price for Amneal Pharmaceuticals Inc Class A (AMRX)

Loading...

Unadjusted Closing Price for Amneal Pharmaceuticals Inc Class A (AMRX)

Loading...

Share Trading Volume for Amneal Pharmaceuticals Inc Class A Shares

Loading...

Compare Performance of Amneal Pharmaceuticals Inc Class A Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AMRX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Amneal Pharmaceuticals Inc Class A (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
4507
Shionogi & Co Ltd 0.00 (0.00%) USD2,049.29B 9.46 9.65

ETFs Containing AMRX

Symbol Name AMRX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Amneal Pharmaceuticals Inc Class A (AMRX) Stock

Based on ratings from 3 analysts Amneal Pharmaceuticals Inc Class A's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on AMRX's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for AMRX is USD 5.75 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 5.

AMRX stock's Price/Earning ratio is 75.33. Our analysis grades AMRX stock's Price / Earning ratio at F. This means that AMRX stock's Price/Earning ratio is above 86% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this AMRX may be a overvalued for its sector.

The last closing price of AMRX's stock was USD 4.29.

The most recent market capitalization for AMRX is USD 1.39B.

Based on targets from 3 analysts, the average taret price for AMRX is projected at USD 5.75 over the next 12 months. This means that AMRX's stock price may go up by +34.03% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...